PSA PROGRESSION
Clinical trials for PSA PROGRESSION explained in plain language.
Never miss a new study
Get alerted when new PSA PROGRESSION trials appear
Sign up with your email to follow new studies for PSA PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Precision radiation after prostate surgery shows promise in cancer control
Disease control OngoingThis study tests a precise type of radiation called stereotactic body radiotherapy (SBRT) in 92 men who had prostate cancer surgery but still have signs of cancer, like rising PSA levels. The goal is to see if SBRT can stop the cancer from coming back while limiting side effects.…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:37 UTC
-
New hope for tough prostate cancer: drug cocktail trial underway
Disease control OngoingThis study tests different combinations of approved drugs to see which works best for men with advanced prostate cancer that has stopped responding to hormone therapy. About 200 men will receive either a standard hormone-blocking combo or that combo plus an immunotherapy or chemo…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:34 UTC
-
Can a mushroom supplement slow prostate cancer?
Disease control OngoingThis study tests whether white button mushroom supplements can lower PSA levels in men with prostate cancer that has returned or is low-risk and not yet treated. About 133 participants take the supplement or follow standard monitoring. The goal is to see if the mushrooms affect P…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 11, 2026 20:41 UTC
-
Immunotherapy drug shows promise for Tough-to-Treat prostate cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab can help men with advanced prostate cancer that has stopped responding to the hormone therapy enzalutamide. About 58 men whose cancer continued to grow despite enzalutamide will receive pembrolizumab. The main g…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 11, 2026 20:40 UTC